STOCK TITAN
  1. Home
  2. Sec-filings
  3. JAGX
  4. [EFFECT] Jaguar Health, Inc. SEC Filing

[EFFECT] Jaguar Health, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 27, 2025 4:00 P.M.
Form: S-3
CIK: 0001585608
Company Name: Jaguar Health, Inc.
File Number: 333-288202

Source: View Original Filing on SEC EDGAR

Stock JAGX logo
Jaguar Health Inc

NASDAQ:JAGX

JAGX Rankings

#6289 Ranked by Market Cap
N/A Ranked by Dividends

JAGX Latest News

Aug 14, 2025
Jaguar Health Reports Second Quarter 2025 Financials: Net Q2 2025 Revenue Up Approximately 35% Versus Net Q1 2025 Revenue
Aug 12, 2025
Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8:30 AM Eastern Regarding Q2 2025 Financials & Corporate Updates
Jul 10, 2025
Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs
Jul 8, 2025
Coca Access and Benefit Sharing Agreement Authorized by Peru's National Institute of Agrarian Innovation (INIA) Supports Research Efforts of Jaguar Health and Filament Health Joint Venture, Magdalena Biosciences, into Potential Mental Health and CNS Indications of Coca
Jun 30, 2025
Proof-of-Concept Results Show Jaguar Health's Crofelemer Reduced Total Parenteral Nutrition in Third Intestinal Failure Orphan Disease Patient

JAGX Latest SEC Filings

Aug 14, 2025
[SCHEDULE 13G/A] Jaguar Health, Inc. SEC Filing
Aug 14, 2025
[8-K] Jaguar Health, Inc. Reports Material Event
Aug 14, 2025
[424B5] Jaguar Health, Inc. Prospectus Supplement (Debt Securities)
Aug 14, 2025
[10-Q] Jaguar Health, Inc. Quarterly Earnings Report
Jul 24, 2025
[S-3] Jaguar Health, Inc. Shelf Registration Statement

JAGX Stock Data

4.96M
1.76M
8.15%
4.55%
2.43%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN FRANCISCO